SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. Financials Shanghai United Imaging Healthcare Co., Ltd.
Equities
688271
CNE100005PN5
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 131.5 CNY | +0.57% |
|
-0.79% | -4.01% |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 145,859 | 112,918 | 107,765 | - | - |
| Enterprise Value (EV) 1 | 135,816 | 105,394 | 98,467 | 97,187 | 95,128 |
| P/E ratio | 80.8 x | 57.1 x | 45.7 x | 37.3 x | 30.1 x |
| Yield | 0.11% | 0.18% | 0.27% | 0.28% | 0.43% |
| Capitalization / Revenue | 15.8 x | 9.9 x | 7.81 x | 6.17 x | 5.12 x |
| EV / Revenue | 14.7 x | 9.24 x | 7.14 x | 5.56 x | 4.52 x |
| EV / EBITDA | 61.7 x | 42.7 x | 37.9 x | 29.6 x | 24.5 x |
| EV / FCF | -2,391 x | -112 x | 58.9 x | 55.4 x | 36.1 x |
| FCF Yield | -0.04% | -0.89% | 1.7% | 1.8% | 2.77% |
| Price to Book | 8.34 x | 5.99 x | 5.16 x | 4.65 x | 3.96 x |
| Nbr of stocks (in thousands) | 824,158 | 824,158 | 819,441 | - | - |
| Reference price 2 | 177.0 | 137.0 | 131.5 | 131.5 | 131.5 |
| Announcement Date | 2/27/23 | 2/27/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | 9,238 | 11,411 | 13,799 | 17,467 | 21,062 |
| EBITDA 1 | - | 2,201 | 2,467 | 2,596 | 3,282 | 3,876 |
| EBIT 1 | - | 1,928 | 2,142 | 2,629 | 3,327 | 3,994 |
| Operating Margin | - | 20.87% | 18.77% | 19.05% | 19.05% | 18.96% |
| Earnings before Tax (EBT) 1 | - | 1,920 | 2,142 | 2,684 | 3,350 | 4,129 |
| Net income 1 | 1,417 | 1,656 | 1,974 | 2,366 | 2,902 | 3,588 |
| Net margin | - | 17.93% | 17.3% | 17.15% | 16.62% | 17.04% |
| EPS 2 | 1.960 | 2.190 | 2.400 | 2.876 | 3.529 | 4.376 |
| Free Cash Flow 1 | - | -56.8 | -943.2 | 1,672 | 1,754 | 2,634 |
| FCF margin | - | -0.61% | -8.27% | 12.12% | 10.04% | 12.51% |
| FCF Conversion (EBITDA) | - | - | - | 64.42% | 53.42% | 67.97% |
| FCF Conversion (Net income) | - | - | - | 70.69% | 60.42% | 73.42% |
| Dividend per Share 2 | - | 0.2010 | 0.2500 | 0.3575 | 0.3717 | 0.5600 |
| Announcement Date | 7/28/22 | 2/27/23 | 2/27/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,687 | 3,380 | 2,213 | 3,058 | 5,271 | 2,161 | 3,978 | 2,350 | 3,438 | 2,798 | 5,196 | 3,043 | - |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBIT | -65.84 | 908.4 | 363.2 | 348.5 | 577.8 | 117.4 | - | 400.4 | - | - | - | - | - |
| Operating Margin | -3.9% | 26.88% | 16.41% | 11.39% | 10.96% | 5.43% | - | 17.04% | - | - | - | - | - |
| Earnings before Tax (EBT) | - | - | - | 687.7 | 1,047 | 119.2 | - | 399.7 | - | - | - | - | - |
| Net income | - | - | - | 608.1 | 937.8 | 126.5 | - | - | - | - | - | - | - |
| Net margin | - | - | - | 19.88% | 17.79% | 5.85% | - | - | - | - | - | - | - |
| EPS 2 | - | - | - | - | - | - | - | 0.4400 | 0.8500 | 0.4500 | 1.140 | 0.6600 | 0.9900 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 10/28/22 | 2/27/23 | 4/27/23 | 8/18/23 | 8/18/23 | 10/27/23 | 2/27/24 | 4/27/24 | - | - | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | - | 10,043 | 7,524 | 9,298 | 10,578 | 12,636 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -56.8 | -943 | 1,673 | 1,754 | 2,635 |
| ROE (net income / shareholders' equity) | - | 17.5% | 10.8% | 11.8% | 12.7% | 14.4% |
| ROA (Net income/ Total Assets) | - | 9.58% | 7.97% | 9.17% | 9.55% | 11.5% |
| Assets 1 | - | 17,283 | 24,770 | 25,811 | 30,389 | 31,201 |
| Book Value Per Share 2 | - | 21.20 | 22.90 | 25.50 | 28.30 | 33.20 |
| Cash Flow per Share 2 | - | 0.8300 | 0.1600 | 2.340 | 3.530 | 3.620 |
| Capex 1 | - | 740 | 1,076 | 693 | 936 | 628 |
| Capex / Sales | - | 8.01% | 9.43% | 5.02% | 5.36% | 2.98% |
| Announcement Date | 7/28/22 | 2/27/23 | 2/27/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
131.5
CNY
Average target price
155
CNY
Spread / Average Target
+17.89%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.01% | 14.84B | |
| -35.44% | 3.09B | |
| -14.59% | 2.44B | |
| -11.01% | 1.52B | |
| -.--% | 1.12B | |
| +57.16% | 583M | |
| +94.87% | 514M | |
| +12.77% | 246M | |
| +0.12% | 227M | |
| +4.07% | 189M |
- Stock Market
- Equities
- 688271 Stock
- Financials Shanghai United Imaging Healthcare Co., Ltd.